21st.Bio: Pioneering Biotechnology in the Dairy Industry
21st.Bio is a biotechnology company based in Denmark, recognized for its innovative approach in the production of alternative proteins through precision fermentation. The company is at the forefront of biotechnological advancements, focusing on sustainable and efficient production methods in the dairy industry.
Innovative Products
The company has developed BLG Essential+, a bovine beta-lactoglobulin product. This is part of their broader strategy to utilize precision fermentation for producing well-characterized proteins that can serve as alternatives in the traditional dairy market. BLG Essential+ represents a significant leap in the application of biotechnology to develop dairy proteins without the use of animals.
Regulatory Developments
21st.Bio has applied for EU Novel Food authorisation, signaling its intention to expand its market presence into Europe. The company is actively seeking a faster authorisation route for its well-characterized protein products, highlighting its commitment to making its innovative solutions accessible in key markets.
Strategic Goals
By seeking entry into Europe's dairy-protein market, 21st.Bio aims to establish itself as a leader in the alternative protein sector. The company's focus on precision fermentation aligns with global trends towards sustainable food production and positions it strategically to meet growing consumer demand for innovative and environmentally friendly food products.
Modified: 2026/11/20